V M Borderie1, S Scheer, T Bourcier
1Cornea Bank of EFS--Ile-de-France and Centre Hospitalier National d'Ophtalmologie des XV-XX, 28 rue de Charenton, 75012 Paris, France. borderie@quinze-vingts.fr
Pre-transplant anticorneal antibodies (IgM) were detected in 28% of patients undergoing penetrating keratoplasty. However, these donor-specific antibodies did not increase the risk of corneal transplant rejection or failure.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: